Fuzai Yin

1.1k total citations
72 papers, 781 citations indexed

About

Fuzai Yin is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Fuzai Yin has authored 72 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Epidemiology and 19 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Fuzai Yin's work include Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers), Obesity, Physical Activity, Diet (15 papers) and Blood Pressure and Hypertension Studies (10 papers). Fuzai Yin is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers), Obesity, Physical Activity, Diet (15 papers) and Blood Pressure and Hypertension Studies (10 papers). Fuzai Yin collaborates with scholars based in China, Australia and United Kingdom. Fuzai Yin's co-authors include Chun‐Ming Ma, Qiang Lü, Xiaoli Liu, Bowei Liu, Na Lü, Rui Wang, Dongmei Fan, Rui Wang, Alison M. Coates and Yue Wang and has published in prestigious journals such as PEDIATRICS, Scientific Reports and Annals of Oncology.

In The Last Decade

Fuzai Yin

68 papers receiving 767 citations

Peers

Countries citing papers authored by Fuzai Yin

Since Specialization

Citations

This map shows the geographic impact of Fuzai Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuzai Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuzai Yin more than expected).

Fields of papers citing papers by Fuzai Yin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuzai Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuzai Yin. The network helps show where Fuzai Yin may publish in the future.

Co-authorship network of co-authors of Fuzai Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Fuzai Yin. A scholar is included among the top collaborators of Fuzai Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuzai Yin. Fuzai Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Relationships Between the Apolipoprotein Levels and Sarcopenia in Inpatients with Type 2 Diabetes Mellitus: A Cross-Sectional Study 2024 ·Diabetes Metabolic Syndrome and Obesity ·Yang Sun, Bowei Liu, Xin Zhang, Fuzai Yin	3
2	Total sugar intake is associated with higher prevalence of depressive symptoms in obese adults 2023 ·Frontiers in Public Health ·Ping Li, Fuzai Yin, (unknown), Yali Liu, Ru Zhang, Jia Wang, Wenqi Lü, Qingsheng Wang, Jing Zhang	7
3	Age, Pulse, Urea, and Albumin Score: A Tool for Predicting the Short-Term and Long-Term Outcomes of Community-Acquired Pneumonia Patients With Diabetes 2022 ·Frontiers in Endocrinology ·Chun‐Ming Ma, Ning Wang, (unknown), Yan Yan, (unknown), (unknown), Xiaoli Liu, (unknown), Na Lü, (unknown), Fuzai Yin	7
4	Performance of Two Novel Obesity Indicators for the Management of Metabolic Syndrome in Young Adults 2021 ·Frontiers in Endocrinology ·Xiaoli Liu, (unknown), (unknown), Fuzai Yin, (unknown), Qiang Lü, Na Lü, Chun‐Ming Ma	3
5	155P Surufatinib plus toripalimab for second-line treatment of advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma, esophageal squamous cell carcinoma (ESCC) and neuroendocrine carcinoma (NEC): A multicenter, single-arm phase II study 2021 ·Annals of Oncology ·Ming Lu, Xianjun Yu, Zewen Chen, (unknown), (unknown), X. Zhang, Fuzai Yin, (unknown), Ying Cheng, Lijie Song, Jianming Xu, (unknown), Haiyan Shi, Peng Tan, Songhua Fan, Weiguo Su, Lin Shen	0
6	MiR-192-5p suppresses M1 macrophage polarization via epiregulin (EREG) downregulation in gouty arthritis 2021 ·Tissue and Cell ·(unknown), Fuzai Yin	18
7	<p>Glycosylated Hemoglobin A1c Improves the Performance of the Nomogram for Predicting the 5-Year Incidence of Type 2 Diabetes</p> 2020 ·Diabetes Metabolic Syndrome and Obesity ·Chun‐Ming Ma, Fuzai Yin	5
8	<p>The Effects of Type 2 Diabetes and Postoperative Pneumonia on the Mortality in Inpatients with Surgery</p> 2019 ·Diabetes Metabolic Syndrome and Obesity ·Chun‐Ming Ma, Qin Liu, Mingli Li, (unknown), Jiandong Zhang, (unknown), Fuzai Yin	17
9	Hypertriglyceridemic waist phenotype and abnormal glucose metabolism: a system review and meta-analysis 2019 ·Endocrine ·Chun‐Ming Ma, Xiaoli Liu, Na Lü, Rui Wang, Qiang Lü, Fuzai Yin	20
10	<p>Relationship between body-roundness index and metabolic syndrome in type 2 diabetes</p> 2019 ·Diabetes Metabolic Syndrome and Obesity ·Bowei Liu, (unknown), (unknown), Fuzai Yin	32
11	Safety and Efficacy of High Versus Standard Starting Doses of Insulin Glargine in Overweight and Obese Chinese Individuals with Type 2 Diabetes Mellitus Inadequately Controlled on Oral Antidiabetic Medications (Beyond VII): Study Protocol for a Randomized Controlled Trial 2018 ·Advances in Therapy ·Linong Ji, Zhengnan Gao, Bimin Shi, Rongwen Bian, Fuzai Yin, Wuyan Pang, Hong Gao, (unknown)	4
12	Three novel obese indicators perform better in monitoring management of metabolic syndrome in type 2 diabetes 2017 ·Scientific Reports ·Chun‐Ming Ma, Na Lü, Rui Wang, Xiaoli Liu, Qiang Lü, Fuzai Yin	30
13	How to Simplify the Diagnostic Criteria of Metabolic Syndrome in Adolescents 2016 ·Pediatrics & Neonatology ·Chun‐Ming Ma, Fuzai Yin, Xiaoli Liu, Rui Wang, (unknown), Qiang Lü	8
14	A new modified blood pressure-to-height ratio simplifies the screening of hypertension in Han Chinese children 2016 ·Hypertension Research ·Chun‐Ming Ma, Qiang Lü, Rui Wang, Xiaoli Liu, (unknown), Fuzai Yin	6
15	The performance of modified blood pressure-to-height ratio as a screening measure for identifying children with hypertension 2015 ·Clinical and Experimental Hypertension ·Chun‐Ming Ma, Qiang Lü, Fuzai Yin	5
16	Neck circumference is an accurate and simple index for evaluating overweight and obesity in Han children 2012 ·Annals of Human Biology ·(unknown), Fuzai Yin, (unknown), Chun‐Ming Ma, Xiaoli Liu, Qiang Lü	41
17	The relationship between the waist-to-height ratio and glucose and lipid metabolism in Han adolescents 2010 ·The Indian Journal of Pediatrics ·Qiang Lü, Tristan J. Iseli, Fuzai Yin, Chun‐Ming Ma, Bowei Liu, (unknown), Xiaoli Liu	4
18	How to simplify the diagnostic criteria of hypertension in adolescents 2010 ·Journal of Human Hypertension ·Qiang Lü, Alison M. Coates, Fuzai Yin, (unknown), (unknown), (unknown)	58
19	Factors Associated with Insulin Resistance and Fasting Plasma Ghrelin Levels in Adolescents with Obesity and Family History of Type 2 Diabetes 2009 ·Experimental and Clinical Endocrinology & Diabetes ·Bowei Liu, (unknown), Chun‐Ming Ma, Shuyi Wang, (unknown), Xiaoli Lou, Fuzai Yin	11
20	[The best waist circumference cut-point for identifying cardiovascular risk factors among adolescents: a preliminary study]. 2008 ·PubMed ·Fuzai Yin, Qiang Lü, Chun‐Ming Ma, Bowei Liu, (unknown), (unknown), (unknown), (unknown), Yi Shen, (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact